Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
Taiwan · Delayed Price · Currency is TWD 31.25
-0.50 (-1.57%)
Jul 30, 2026, 12:34 PM CST
Nang Kuang Pharmaceutical Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,112 | 2,162 | 2,200 | 2,150 | 1,940 | 1,780 |
Revenue Growth | -6.15% | -1.71% | 2.31% | 10.81% | 9.01% | 1.44% |
Gross Profit Gross Profit Growth | 736.53 | 768.86 | 747.79 | 755.56 | 694.9 | 594.47 |
Operating Income Operating Income Growth | 263.22 | 295.67 | 310.22 | 259.84 | 321.67 | 254.48 |
Net Income Net Income Growth | 204.95 | 244.41 | 243.41 | 198.41 | 352 | 196.11 |
Earnings Per Share EPS Growth | 2.02 | 2.41 | 2.40 | 1.96 | 3.48 | 1.94 |
EPS Growth | -21.38% | 0.42% | 22.45% | -43.68% | 79.38% | 7.18% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Taiwan Taiwan Growth | 1,692 | 1,703 | 1,612 | 1,421 | 1,306 | 1,173 |
Other Countries Other Countries Growth | 28.91 | 67.6 | 64.31 | 54.45 | 34.82 | 26.62 |
Mainland China Mainland China Growth | - | 209.24 | 239.74 | 407.41 | 184.15 | 362.6 |
Japan Japan Growth | - | 101.06 | 190.08 | 207.07 | 240.93 | 95.64 |
United States United States Growth | - | 81.45 | 93.24 | 60.37 | 174.14 | 122.59 |
Total Total Growth | 2,112 | 2,162 | 2,200 | 2,150 | 1,940 | 1,780 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 327.26 | 345.67 | 301.54 | 378.48 | 402.51 | 418.41 |
Total Debt Total Debt Growth | 693.64 | 655.69 | 638.23 | 705.56 | 409.13 | 532.81 |
Net Cash (Debt) Net Cash Growth | -366.38 | -310.02 | -336.69 | -327.08 | -6.62 | -114.4 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3.62 | -3.06 | -3.33 | -3.23 | -0.07 | -1.13 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 358.82 | 464.08 | 466.43 | 342.61 | 369.19 | 556.63 |
Capital Expenditures CapEx Growth | -317.16 | -277.82 | -524.6 | -297.51 | -93.84 | -156.05 |
Free Cash Flow Free Cash Flow Growth | 41.65 | 186.25 | -58.17 | 45.1 | 275.35 | 400.58 |
Free Cash Flow Growth | 59.61% | - | - | -83.62% | -31.26% | 558.08% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 34.87% | 35.56% | 33.99% | 35.14% | 35.81% | 33.40% |
Operating Margin | 12.46% | 13.67% | 14.10% | 12.08% | 16.58% | 14.30% |
Pretax Margin | 11.51% | 13.47% | 13.78% | 9.94% | 21.16% | 13.19% |
Profit Margin | 9.70% | 11.30% | 11.06% | 9.23% | 18.14% | 11.02% |
FCF Margin | 1.97% | 8.61% | -2.64% | 2.10% | 14.19% | 22.50% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.600 | - | 1.600 | 2.000 | 2.300 | 1.800 |
Dividend Per Share Growth | 0% | - | -20.00% | -13.04% | 27.78% | 12.50% |
Dividend Yield | 5.05% | - | 4.27% | 4.28% | 4.26% | 5.82% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.72 | 15.41 | 17.07 | 27.13 | 18.33 | 19.83 |
Forward PE | - | 14.92 | 17.95 | 19.68 | 21.30 | 14.55 |
P/FCF Ratio | 76.98 | 20.22 | - | 119.36 | 23.44 | 9.71 |
PS Ratio | 1.52 | 1.74 | 1.89 | 2.50 | 3.33 | 2.18 |